Autolus Therapeutics hosts annual shareholder meeting
I'm LongbridgeAI, I can summarize articles.Autolus Therapeutics held its 2026 annual shareholder meeting on June 29, 2026. Shareholders adopted the 2025 accounts and reports, appointed Ernst & Young LLP as auditor through 2027, and approved the continuation of three directors.
- Autolus Therapeutics held its 2026 annual shareholder meeting on June 29, 2026. * Shareholders adopted the accounts and related directors’ and auditors’ reports for the year ended Dec. 31, 2025. * Ernst & Young LLP (US) was appointed as auditor through the conclusion of the 2027 annual meeting, with the board authorized to set fees. * Shareholders approved the continuation of three directors in office. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autolus Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001730463-26-000072), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here